Back to Search
Start Over
Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study
- Source :
- Blood; November 2011, Vol. 118 Issue: 21 p3069-3069, 1p
- Publication Year :
- 2011
-
Abstract
- Abstract 3069FN2This icon denotes a clinically relevant abstract
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 118
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56786762
- Full Text :
- https://doi.org/10.1182/blood.V118.21.3069.3069